The “one airway, one disease” concept in light of Th2 inflammation

European Respiratory Journal

Volumn 52, Issue 4, 2018, Pages

  Giovannini Chami, Lisa ^a,b   Paquet, Agnès ^b   Sanfiorenzo, Céline ^a   Pons, Nicolas ^b   Cazareth, Julie ^b   Magnone, Virginie ^b   Lebrigand, Kévin ^b   Chevalier, Benoit ^b   Vallauri, Ambre ^b   Julia, Valérie ^b   Marquette, Charles Hugo ^a   Marcet, Brice ^b   Leroy, Sylvie ^a   Barbry, Pascal ^b  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BRONCHIAL CELL LINE; BRONCHUS EPITHELIUM; CELL COMPOSITION; CELL COUNT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MALE; MAST CELL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; RNA SEQUENCE; TH17 CELL; TH2 CELL; BRONCHOALVEOLAR LAVAGE FLUID; CASE CONTROL STUDY; CYTOLOGY; GENE EXPRESSION; IMMUNOLOGY; INFLAMMATION; METABOLISM; NASAL LAVAGE FLUID; PATHOPHYSIOLOGY; RESPIRATORY MUCOSA; SEQUENCE ANALYSIS; YOUNG ADULT;

ADULT; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION; INTERFERONS; MALE; NASAL LAVAGE FLUID; RESPIRATORY MUCOSA; RHINITIS, ALLERGIC; SEQUENCE ANALYSIS, RNA; TH17 CELLS; TH2 CELLS; YOUNG ADULT;

EID: 85055616749     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00437-2018     Document Type: Article

References (41)

1. Simons FE. Allergic rhinobronchitis: the asthma-allergic rhinitis link. J Allergy Clin Immunol 1999; 104: 534–540.
2. Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol 2003; 111: 1171–1183.
3. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63: Suppl. 86, 8–160.
4. Leynaert B, Bousquet J, Neukirch C, et al. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999; 104: 301–304.
5. Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 2008; 372: 1049–1057.
6. McDougall CM, Blaylock MG, Douglas JG, et al. Nasal epithelial cells as surrogates for bronchial epithelial cells in airway inflammation studies. Am J Respir Cell Mol Biol 2008; 39: 560–568.
7. McLellan K, Shields M, Power U, et al. Primary airway epithelial cell culture and asthma in children-lessons learnt and yet to come. Pediatr Pulmonol 2015; 50: 1393–1405.
8. Woodruff PG, Boushey HA, Dolganov GM, et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci USA 2007; 104: 15858–15863.
9. Giovannini-Chami L, Marcet B, Moreilhon C, et al. Distinct epithelial gene expression phenotypes in childhood respiratory allergy. Eur Respir J 2012; 39: 1197–1205.
10. Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med 2011; 365: 1088–1098.
11. Robinson D, Humbert M, Buhl R, et al. Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy 2017; 47: 161–175.
12. 2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lancet 2016; 388: 31–44.
13. Ortega HG, Liu MC, Pavord ID, et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med 2014; 371: 1198–1207.
14. Bel EH, Wenzel SE, Thompson PJ, et al. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med 2014; 371: 1189–1197.
15. Choy DF, Hart KM, Borthwick LA, et al. TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. Sci Transl Med 2015; 7: 301ra129.
16. Bhakta NR, Christenson SA, Nerella S, et al. IFN-stimulated gene expression, type 2 inflammation, and endoplasmic reticulum stress in asthma. Am J Respir Crit Care Med 2018; 197: 313–324.
17. Woodruff PG, Modrek B, Choy DF, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009; 180: 388–395.
18. Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010; 126: 466–476.
19. GINA Report. Global Strategy for Asthma Management and Prevention. 2012. http://ginasthma.org/
20. National Heart, Lung, and Blood Institute (NHLBI). Expert panel report 3: guidelines for the diagnosis and management of asthma. Bethesda, NHLBI, 2007. www.nhlbi.nih.gov/files/docs/guidelines/asthgdln.pdf Date last accessed: September 17, 2018.
21. Le Brigand K, Barbry P. Mediante: a web-based microarray data manager. Bioinformatics 2007; 23: 1304–1306.
22. Alevy YG, Patel AC, Romero AG, et al. IL-13-induced airway mucus production is attenuated by MAPK13 inhibition. J Clin Invest 2012; 122: 4555–4568.
23. Zhen G, Park SW, Nguyenvu LT, et al. IL-13 and epidermal growth factor receptor have critical but distinct roles in epithelial cell mucin production. Am J Respir Cell Mol Biol 2007; 36: 244–253.
24. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5: R80.
25. Choy DF, Modrek B, Abbas AR, et al. Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airways. J Immunol 2011; 186: 1861–1869.
26. Compalati E, Ridolo E, Passalacqua G, et al. The link between allergic rhinitis and asthma: the united airways disease. Expert Rev Clin Immunol 2010; 6: 413–423.
27. Lopez-Souza N, Favoreto S, Wong H, et al. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J Allergy Clin Immunol 2009; 123: 1384–1390.
28. Bousquet J, Jacot W, Vignola AM, et al. Allergic rhinitis: a disease remodeling the upper airways? J Allergy Clin Immunol 2004; 113: 43–49.
29. Comer DM, Elborn JS, Ennis M. Comparison of nasal and bronchial epithelial cells obtained from patients with COPD. PLoS One 2012; 7: e32924.
30. Kuo CS, Pavlidis S, Loza M, et al. A transcriptome-driven analysis of epithelial brushings and bronchial biopsies to define asthma phenotypes in U-BIOPRED. Am J Respir Crit Care Med 2017; 195: 443–455.
31. Pavord ID, Afzalnia S, Menzies-Gow A, et al. The current and future role of biomarkers in type 2 cytokine-mediated asthma management. Clin Exp Allergy 2017; 47: 148–160.
32. Hanania NA, Korenblat P, Chapman KR, et al. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med 2016; 4: 781–796.
33. Peters MC, Mekonnen ZK, Yuan S, et al. Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. J Allergy Clin Immunol 2014; 133: 388–394.
34. Kuo CS, Pavlidis S, Loza M, et al. T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED. Eur Respir J 2017; 49: 1602135.
35. Poole A, Urbanek C, Eng C, et al. Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease. J Allergy Clin Immunol 2014; 133: 670–678.
36. Marcet B, Chevalier B, Luxardi G, et al. Control of vertebrate multiciliogenesis by miR-449 through direct repression of the Delta/Notch pathway. Nat Cell Biol 2011; 13: 693–699.
37. Wesolowska-Andersen A, Everman JL, Davidson R, et al. Dual RNA-seq reveals viral infections in asthmatic children without respiratory illness which are associated with changes in the airway transcriptome. Genome Biol 2017; 18: 12.
38. Bhakta NR, Solberg OD, Nguyen CP, et al. A qPCR-based metric of Th2 airway inflammation in asthma. Clin Transl Allergy 2013; 3: 24.
39. Braunstahl GJ, Fokkens WJ, Overbeek SE, et al. Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: a comparison between upper and lower airways. Clin Exp Allergy 2003; 33: 579–587.
40. Edwards MR, Strong K, Cameron A, et al. Viral infections in allergy and immunology: how allergic inflammation influences viral infections and illness. J Allergy Clin Immunol 2017; 140: 909–920.
41. Hart KM, Choy DF, Bradding P, et al. Accurately measuring and modeling Th2 and Th17 endotypes in severe asthma. Ann Transl Med 2017; 5: 91.